Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

ADC Therapeutics Stock News

ADCTNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$3.67

0.102.80%

At close: -

$3.67

0.000.00%

After Hours: 5:27 PM EDT

ADC Therapeutics (ADCT) Forecast

News

Earnings ADC Therapeutics (ADCT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest ADC Therapeutics Stock News | NYSE:ADCT | Benzinga

Get the latest news on ADC Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on ADC Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, May 15, 2025

RBC Capital Reiterates Outperform on ADC Ther...
Benzinga Newsdesk

Wednesday, May 14, 2025

ADC Therapeutics shares are trading higher af...
Benzinga Newsdesk
ADC Therapeutics Q1 Adj. EPS $(0.22) Beats $(...
Benzinga Newsdesk
ADC Therapeutics Presents Data From LOTIS-7 P...
Benzinga Newsdesk
Earnings Scheduled For May 14, 2025
Benzinga Insights

Tuesday, May 13, 2025

Preview: ADC Therapeutics's Earnings
Benzinga Insights

Monday, April 28, 2025

ADC Therapeutics shares are trading higher af...
Benzinga Newsdesk
ADC Therapeutics' Claudin-6 Targeting ADC Sho...
Benzinga Newsdesk

Monday, March 31, 2025

Guggenheim Maintains Buy on ADC Therapeutics,...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on ADC The...
Benzinga Newsdesk

Thursday, March 27, 2025

ADC Therapeutics Says $250.9M In Cash As Of D...
Benzinga Newsdesk
ADC Therapeutics Q4 2024 Adj EPS $(0.25) Beat...
Benzinga Newsdesk
Earnings Scheduled For March 27, 2025
Benzinga Insights

Wednesday, March 26, 2025

A Preview Of ADC Therapeutics's Earnings
Benzinga Insights

Friday, March 07, 2025

Cantor Fitzgerald Reiterates Overweight on AD...
Benzinga Newsdesk

Monday, February 24, 2025

Stephens & Co. Maintains Overweight on ADC Th...
Benzinga Newsdesk

Monday, January 06, 2025

HC Wainwright & Co. Reiterates Buy on ADC The...
Benzinga Newsdesk

Monday, December 30, 2024

ADC Therapeutics Completes Enrollment In LOTI...
Benzinga Newsdesk

Thursday, December 12, 2024

Guggenheim Reiterates Buy on ADC Therapeutics...
Benzinga Newsdesk

Wednesday, December 11, 2024

HC Wainwright & Co. Reiterates Buy on ADC The...
Benzinga Newsdesk
ADC Therapeutics shares are trading higher af...
Benzinga Newsdesk
ADC Therapeutics Announced Positive Initial D...
Benzinga Newsdesk

Friday, December 06, 2024

ADC Therapeutics shares are trading higher af...
Benzinga Newsdesk
ADC Therapeutics Says It Will Provide Initial...
Benzinga Newsdesk

Friday, November 08, 2024

ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why
Vandana Singh
Stephens & Co. Initiates Coverage On ADC Ther...
Benzinga Newsdesk

Thursday, November 07, 2024

ADC Therapeutics Q3 2024 Adj. EPS $(0.28) Bea...
Benzinga Newsdesk

Wednesday, November 06, 2024

ADC Therapeutics's Earnings: A Preview
Benzinga Insights

Thursday, August 08, 2024

HC Wainwright & Co. Reiterates Buy on ADC The...
Benzinga Newsdesk

Wednesday, August 07, 2024

RBC Capital Reiterates Outperform on ADC Ther...
Benzinga Newsdesk

Tuesday, August 06, 2024

ADC Therapeutics' Cash And Cash Equivalents W...
Benzinga Newsdesk
ADC Therapeutics Q2 2024 Adj. EPS $(0.25) Bea...
Benzinga Newsdesk

Monday, July 08, 2024

Intapp, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor

Thursday, June 27, 2024

ADC Therapeutics Is Set To Join The Russell 2...
Benzinga Newsdesk

Thursday, May 30, 2024

Cantor Fitzgerald Initiates Coverage On ADC T...
Benzinga Newsdesk

Tuesday, May 07, 2024

HC Wainwright & Co. Maintains Buy on ADC Ther...
Benzinga Newsdesk

Monday, May 06, 2024

BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
ADC Therapeutics Currently Expects Its Cash R...
Benzinga Newsdesk
ADC Therapeutics Q1 2024 Adj EPS $(0.38) Beat...
Benzinga Newsdesk
ADC Therapeutics Announces Initial Data from ...
Benzinga Newsdesk

Tuesday, April 30, 2024

Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor

Monday, April 15, 2024

HC Wainwright & Co. Reiterates Buy on ADC The...
Benzinga Newsdesk

Friday, April 05, 2024

Guggenheim Reiterates Buy on ADC Therapeutics
Benzinga Newsdesk

Thursday, April 04, 2024

ADC Therapeutics shares are trading higher. T...
Benzinga Newsdesk
ADC Therapeutics Announces Updates on LOTIS-7...
Benzinga Newsdesk

Thursday, March 28, 2024

ADC Therapeutics shares are trading higher af...
Benzinga Newsdesk
Guggenheim Initiates Coverage On ADC Therapeu...
Benzinga Newsdesk

Thursday, March 14, 2024

RBC Capital Reiterates Outperform on ADC Ther...
Benzinga Newsdesk

Wednesday, March 13, 2024

Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday
Avi Kapoor
ADC Therapeutics' 2023 Cash And Cash Equivale...
Benzinga Newsdesk

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved